Alliance Pharma, now operating as Resolian, is a global bioanalytical, biomarker, DMPK, and analytical sciences CRO supporting pharmaceutical and biotechnology companies across preclinical, clinical, and commercial-stage drug development. Alliance Pharma and Drug Development Solutions were fully integrated under the Resolian name in 2023, bringing together bioanalytical and analytical science capabilities across the U.S., U.K., Australia, and China.

Overview

Alliance Pharma is built for sponsors that need specialized laboratory support for complex drug development programs. Their work focuses on bioanalysis, biomarker testing, drug metabolism and pharmacokinetics, immunogenicity, analytical chemistry, CMC testing, and materials characterization.

For biotech and pharma teams developing small molecules, biologics, peptides, oligonucleotides, ADCs, cell and gene therapies, and other advanced modalities, Alliance Pharma provides the scientific depth and laboratory infrastructure needed to support development from early discovery through late-stage clinical trials.

Accreditations & Compliance

Alliance Pharma, now Resolian, supports both GxP and non-regulated bioanalysis, DMPK, GMP CMC analytical testing, and materials science services. The company describes its operations as FDA, EMA, and MHRA inspection ready, with harmonized SOPs, reporting templates, global quality systems, and regulatory-ready data integrity across its laboratory network.

For regulated projects, sponsors should confirm study-specific requirements before launch, including GLP, GCP, or GMP status, assay validation expectations, QA review, raw data access, reporting format, sample chain of custody, and intended regulatory submission use.

Core Services

Alliance Pharma provides advanced bioanalytical testing for small and large molecule drug development, including LC-MS/MS, immunoassay, flow cytometry, high-resolution mass spectrometry, PCR, peptide analysis, oligonucleotide bioanalysis, biomarker testing, immunogenicity assays, and drug conjugate analysis.

Their immunogenicity capabilities include anti-drug antibody testing, neutralizing antibody assay support, and assay development and validation for complex biologics and next-generation therapeutic modalities.

Alliance Pharma also supports DMPK, ADME, clinical drug-drug interaction studies, statistical PK analysis, CMC analytical testing, impurity identification, nitrosamine testing, elemental impurity analysis, extractables and leachables, materials characterization, analytical chemistry, trace analysis, and method development and validation.

Technology & Expertise

Alliance Pharma’s expertise is centered on bioanalytical and analytical science for complex therapeutic programs. Their platform includes LC-MS, immunoassay, ligand binding assays, flow cytometry, PCR, high-resolution mass spectrometry, protein and oligonucleotide analysis, biomarker assays, and analytical chemistry capabilities.

Their global laboratory network supports sponsors that need consistent assay execution across regions, including early-phase development in one location and later-phase clinical trial support across multiple geographies. Resolian reports five laboratories across four continents, with specialized capabilities in North America, the United Kingdom, Australia, and China.

Best Fit Projects

Alliance Pharma is a strong fit for projects involving small molecule bioanalysis, large molecule bioanalysis, PK studies, DMPK, ADME, biomarker analysis, immunogenicity testing, ADA and NAb assays, LC-MS/MS method development, oligonucleotide bioanalysis, peptide analysis, ADC bioanalysis, cell and gene therapy assays, PCR-based testing, flow cytometry, CMC analytical testing, impurity characterization, and extractables and leachables.

They are especially well suited for sponsors that need a specialized bioanalytical CRO rather than a broad general-purpose research vendor.

Why Work With Alliance Pharma Through CROaccess

Through CROaccess, sponsors can evaluate Alliance Pharma for bioanalytical, biomarker, DMPK, CMC analytical, and materials science projects while comparing fit against other qualified CROs and specialty laboratories.

Alliance Pharma brings deep technical expertise in regulated bioanalysis and analytical sciences, while CROaccess helps sponsors manage vendor evaluation, proposal collection, documentation, communication, and project tracking in one centralized platform.